Variant report

Variant	esv3493316
Chromosome Location	chr6:165721412-165733110
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:49)
CpG islands
(count:367)
Chromatin interactive
region (count:2)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:49 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CHD2	chr6:165722861-165723245	H1-hESC	embryonic stem cell:	n/a	n/a
2	CHD2	chr6:165722731-165723055	Hela-S3	cervix:	n/a	n/a
3	CTCF	chr6:165722820-165722970	HCPEpiC	choroid plexus:	n/a	n/a
4	E2F6	chr6:165722358-165722715	A549	lung:	n/a	chr6:165722645-165722660
5	E2F6	chr6:165722059-165723307	H1-hESC	embryonic stem cell:	n/a	chr6:165722645-165722660
6	E2F6	chr6:165722203-165723274	H1-hESC	embryonic stem cell:	n/a	chr6:165722645-165722660
7	E2F6	chr6:165722373-165722547	K562	blood:	n/a	n/a
8	ELK1	chr6:165722938-165722976	Hela-S3	cervix:	n/a	n/a
9	GATA2	chr6:165721218-165721628	SH-SY5Y	brain:	n/a	n/a
10	HA-E2F1	chr6:165722465-165723210	MCF-7	breast:	n/a	chr6:165722645-165722660
11	JUN	chr6:165723053-165723253	H1-hESC	embryonic stem cell:	n/a	n/a
12	JUND	chr6:165722982-165723148	H1-hESC	embryonic stem cell:	n/a	n/a
13	JUND	chr6:165722959-165723157	H1-hESC	embryonic stem cell:	n/a	n/a
14	KAP1	chr6:165722694-165723255	U2OS	brain:	n/a	n/a
15	KAP1	chr6:165722299-165723318	HEK293	kidney:	n/a	n/a
16	MAX	chr6:165722322-165723199	H1-hESC	embryonic stem cell:	n/a	n/a
17	MAX	chr6:165722235-165723305	H1-hESC	embryonic stem cell:	n/a	n/a
18	MAX	chr6:165722210-165723123	A549	lung:	n/a	n/a
19	MAX	chr6:165722452-165723119	Hela-S3	cervix:	n/a	n/a
20	MAX	chr6:165722256-165723257	H1-hESC	embryonic stem cell:	n/a	n/a
21	MAX	chr6:165722597-165723090	A549	lung:	n/a	n/a
22	MAX	chr6:165722435-165722541	A549	lung:	n/a	n/a
23	MAZ	chr6:165722656-165723287	IMR90	lung:	n/a	n/a
24	MAZ	chr6:165722769-165722825	Hela-S3	cervix:	n/a	n/a
25	MXI1	chr6:165722535-165723262	IMR90	lung:	n/a	chr6:165723107-165723122 chr6:165723109-165723124
26	MXI1	chr6:165723072-165723238	Hela-S3	cervix:	n/a	chr6:165723107-165723122 chr6:165723109-165723124
27	MXI1	chr6:165722586-165723269	H1-hESC	embryonic stem cell:	n/a	chr6:165723107-165723122 chr6:165723109-165723124
28	MXI1	chr6:165722399-165723472	SK-N-SH	brain:	n/a	chr6:165723107-165723122 chr6:165723109-165723124
29	MXI1	chr6:165722600-165722785	Hela-S3	cervix:	n/a	n/a
30	MYC	chr6:165722714-165722893	MCF-7	breast:	n/a	n/a
31	MYC	chr6:165722509-165722539	H1-hESC	embryonic stem cell:	n/a	n/a
32	POLR2A	chr6:165722942-165723162	H1-hESC	embryonic stem cell:	n/a	n/a
33	POLR2A	chr6:165722616-165723253	H1-neurons	neurons:	n/a	n/a
34	POLR2A	chr6:165722619-165723296	H1-neurons	neurons:	n/a	n/a
35	REST	chr6:165730351-165730533	H1-hESC	embryonic stem cell:	n/a	chr6:165730431-165730441 chr6:165730435-165730444
36	REST	chr6:165730334-165730521	H1-hESC	embryonic stem cell:	n/a	chr6:165730431-165730441 chr6:165730435-165730444
37	SIN3A	chr6:165722471-165723351	H1-hESC	embryonic stem cell:	n/a	chr6:165723168-165723181
38	SIN3AK20	chr6:165722835-165723333	H1-hESC	embryonic stem cell:	n/a	n/a
39	SIN3AK20	chr6:165722871-165723214	PFSK-1	brain:	n/a	n/a
40	SIN3AK20	chr6:165722748-165723232	PFSK-1	brain:	n/a	n/a
41	SIN3AK20	chr6:165722964-165723285	H1-hESC	embryonic stem cell:	n/a	n/a
42	SP1	chr6:165722791-165723291	H1-hESC	embryonic stem cell:	n/a	chr6:165722817-165722827
43	STAT3	chr6:165723521-165723608	MCF10A-Er-Src	breast:	n/a	n/a
44	TEAD4	chr6:165722860-165723219	H1-hESC	embryonic stem cell:	n/a	n/a
45	TEAD4	chr6:165722906-165723294	H1-hESC	embryonic stem cell:	n/a	n/a
46	YY1	chr6:165722887-165723220	H1-hESC	embryonic stem cell:	n/a	n/a
47	YY1	chr6:165722731-165723222	H1-hESC	embryonic stem cell:	n/a	n/a
48	ZNF143	chr6:165722814-165723314	H1-hESC	embryonic stem cell:	n/a	chr6:165723215-165723234
49	ZNF263	chr6:165722354-165723251	HEK293-T-REx	kidney:	n/a	chr6:165722738-165722747 chr6:165722733-165722754 chr6:165722735-165722744 chr6:165722744-165722753 chr6:165722741-165722750 chr6:165723202-165723211

(count:367 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:165724355-165724405	NHDF-neo	bronchial:	n/a
2	chr6:165724355-165724405	NHDF-neo	bronchial:	n/a
3	chr6:165722651-165722701	HPAEpiC	pulmonary alveolar:	n/a
4	chr6:165723796-165723846	A549	lung:	n/a
5	chr6:165723034-165723084	AG09309	skin:	n/a
6	chr6:165724355-165724405	HAEpiC	amniotic membrane:	n/a
7	chr6:165724355-165724405	ECC-1	luminal epithelium:	n/a
8	chr6:165722858-165722908	NB4	blood:	n/a
9	chr6:165723034-165723084	ovcar-3	ovarian:	n/a
10	chr6:165722651-165722701	AG10803	skin:	n/a
11	chr6:165723796-165723846	AoSMC	blood vessel:	n/a
12	chr6:165722858-165722908	SK-N-SH	brain:	n/a
13	chr6:165723796-165723846	NB4	blood:	n/a
14	chr6:165724355-165724405	A549	lung:	n/a
15	chr6:165722651-165722701	GM06990	blood:	n/a
16	chr6:165723796-165723846	HEK293	kidney:	embryo
17	chr6:165723796-165723846	SK-N-SH	brain:	n/a
18	chr6:165724355-165724405	PFSK-1	brain:	n/a
19	chr6:165724355-165724405	NT2-D1	testis:	n/a
20	chr6:165723034-165723084	SKMC	muscle:	n/a
21	chr6:165722858-165722908	HepG2	liver:	n/a
22	chr6:165723708-165723758	NH-A	brain:	n/a
23	chr6:165724355-165724405	GM19239	blood:	n/a
24	chr6:165723796-165723846	PrEC	prostate:	n/a
25	chr6:165724355-165724405	IMR90	lung:	fetal
26	chr6:165722651-165722701	AoSMC	blood vessel:	n/a
27	chr6:165723796-165723846	NT2-D1	testis:	n/a
28	chr6:165723034-165723084	K562	blood:	n/a
29	chr6:165723796-165723846	CMK	blood:	n/a
30	chr6:165722651-165722701	HRPEpiC	eye:	n/a
31	chr6:165722651-165722701	HCPEpiC	choroid plexus:	n/a
32	chr6:165722858-165722908	SK-N-MC	brain:	n/a
33	chr6:165723708-165723758	HRPEpiC	eye:	n/a
34	chr6:165724355-165724405	SK-N-MC	brain:	n/a
35	chr6:165723796-165723846	HCT-116	colon:	n/a
36	chr6:165722858-165722908	K562	blood:	n/a
37	chr6:165723708-165723758	HAEpiC	amniotic membrane:	n/a
38	chr6:165724355-165724405	K562	blood:	n/a
39	chr6:165722651-165722701	AG09309	skin:	n/a
40	chr6:165723034-165723084	HRPEpiC	eye:	n/a
41	chr6:165724355-165724405	HUVEC	blood vessel:	n/a
42	chr6:165722651-165722701	CMK	blood:	n/a
43	chr6:165723034-165723084	PFSK-1	brain:	n/a
44	chr6:165722858-165722908	BJ	skin:	n/a
45	chr6:165722858-165722908	SKMC	muscle:	n/a
46	chr6:165722858-165722908	HEEpiC	esophagus:	n/a
47	chr6:165724355-165724405	HCPEpiC	choroid plexus:	n/a
48	chr6:165723034-165723084	HepG2	liver:	n/a
49	chr6:165724355-165724405	HNPCEpiC	eye:	n/a
50	chr6:165723034-165723084	Jurkat	blood:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr6:165726694..165728455-chr6:165728585..165730141,2	MCF-7	breast:
2	chr6:165726694..165728455-chr6:165728585..165730141,2	MCF-7	breast:

No data

Variant related genes	Relation type
C6orf118	TF binding region
C6orf118	CpG island

Extended variants
information (count: 329 )
Associated
traits (count: 83 )

Variant overlapped rSNPs/rCNVs (count:329 , 50 per page) page: 1 2 3 4 5 6 7

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs73788332	chr6:165721422-165721423	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs540154597	chr6:165721442-165721443	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs187553159	chr6:165721523-165721524	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs34332592	chr6:165721629-165721630	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs67352322	chr6:165721673-165721674	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs567655	chr6:165721710-165721711	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs148754815	chr6:165721776-165721777	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs142265505	chr6:165721789-165721790	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs147464642	chr6:165721816-165721817	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs537543078	chr6:165721843-165721844	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs377216276	chr6:165721846-165721847	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs563658165	chr6:165721859-165721860	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs73788333	chr6:165721865-165721866	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs556255734	chr6:165721900-165721901	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs34399360	chr6:165721931-165721932	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs546290855	chr6:165721952-165721953	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs564704777	chr6:165721957-165721958	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs76234374	chr6:165722022-165722023	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs36008818	chr6:165722027-165722028	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs79999438	chr6:165722047-165722048	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs144473575	chr6:165722052-165722053	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs191724370	chr6:165722057-165722058	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs34936248	chr6:165722157-165722158	Enhancers Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs12660425	chr6:165722205-165722206	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs184274620	chr6:165722250-165722251	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs530538278	chr6:165722268-165722269	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs551817319	chr6:165722293-165722294	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs570520998	chr6:165722311-165722312	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs534563386	chr6:165722343-165722344	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs646444	chr6:165722345-165722346	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs9457069	chr6:165722353-165722354	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs188270951	chr6:165722369-165722370	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs546968	chr6:165722389-165722390	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs575663280	chr6:165722439-165722440	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs546079801	chr6:165722444-165722445	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs558009124	chr6:165722490-165722491	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs573283148	chr6:165722536-165722537	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs564122666	chr6:165722576-165722577	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs635149	chr6:165722603-165722604	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs562290969	chr6:165722680-165722681	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
41	rs377546919	chr6:165722735-165722736	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs529556680	chr6:165722764-165722765	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs377085936	chr6:165722773-165722774	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs562957721	chr6:165722779-165722780	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs530467305	chr6:165722789-165722790	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs112324018	chr6:165722790-165722791	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs62442133	chr6:165722802-165722803	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs192479037	chr6:165722810-165722811	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs550843	chr6:165722832-165722833	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs546493745	chr6:165722833-165722834	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:83)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Developmental delay	21147756	CNVD
Chordoma	18071362	CNVD
Glioblastoma multiforme	19435819	CNVD
Ovarian cancer	21720365	CNVD
Glioblastoma multiforme	21138945	CNVD
abnormal development	18461090	CNVD
Epilepsy	22083797	CNVD
Myelofibrosis	22110671	CNVD
chordoma	19801981	CNVD
Myxofibrosarcoma	16751306	CNVD
Autism	17483303	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Acute myeloid leukemia	19651601	CNVD
Sudden cardiac death	19188705	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Breast cancer	22522925	CNVD
Melanoma	20877625	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:208 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:165714400-165721800	Weak transcription	Fetal Muscle Leg	muscle
2	chr6:165714800-165721600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr6:165721200-165721800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
4	chr6:165721400-165721600	Enhancers	Gastric	stomach
5	chr6:165721400-165721800	Flanking Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
6	chr6:165721400-165721800	Active TSS	Brain Germinal Matrix	brain
7	chr6:165721400-165722200	Enhancers	Cortex derived primary cultured neurospheres	brain
8	chr6:165721400-165722600	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
9	chr6:165721400-165722600	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
10	chr6:165721400-165723200	Active TSS	Brain Anterior Caudate	brain
11	chr6:165721600-165722600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
12	chr6:165721600-165722800	Weak transcription	Gastric	stomach
13	chr6:165721800-165722000	Active TSS	Skeletal Muscle Female	skeletal muscle
14	chr6:165721800-165722200	Enhancers	Esophagus	oesophagus
15	chr6:165721800-165722400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
16	chr6:165721800-165722400	Flanking Active TSS	Brain Germinal Matrix	brain
17	chr6:165721800-165722400	Enhancers	Fetal Muscle Leg	muscle
18	chr6:165721800-165722600	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
19	chr6:165722000-165722200	Enhancers	Fetal Brain Female	brain
20	chr6:165722200-165722400	Enhancers	Breast Myoepithelial Primary Cells	Breast
21	chr6:165722200-165722400	Active TSS	Primary hematopoietic stem cells	blood
22	chr6:165722200-165722400	Enhancers	Muscle Satellite Cultured Cells	--
23	chr6:165722200-165722400	Enhancers	Brain Substantia Nigra	brain
24	chr6:165722200-165722400	Enhancers	Duodenum Mucosa	Duodenum
25	chr6:165722200-165722400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
26	chr6:165722200-165722400	Active TSS	Fetal Brain Male	brain
27	chr6:165722200-165722400	Enhancers	Fetal Kidney	kidney
28	chr6:165722200-165722400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
29	chr6:165722200-165722400	Enhancers	NH-A	brain
30	chr6:165722200-165722600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
31	chr6:165722200-165722600	Weak transcription	Esophagus	oesophagus
32	chr6:165722200-165722600	Flanking Active TSS	Fetal Brain Female	brain
33	chr6:165722200-165722600	Enhancers	Skeletal Muscle Female	skeletal muscle
34	chr6:165722200-165722800	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
35	chr6:165722200-165723200	Active TSS	Brain Hippocampus Middle	brain
36	chr6:165722200-165723200	Active TSS	Fetal Lung	lung
37	chr6:165722200-165723200	Active TSS	HSMM	muscle
38	chr6:165722400-165722600	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
39	chr6:165722400-165722600	Flanking Bivalent TSS/Enh	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
40	chr6:165722400-165722600	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
41	chr6:165722400-165722600	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
42	chr6:165722400-165722600	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
43	chr6:165722400-165722600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
44	chr6:165722400-165722600	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
45	chr6:165722400-165722600	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
46	chr6:165722400-165722600	Flanking Active TSS	Fetal Kidney	kidney
47	chr6:165722400-165722600	Enhancers	Placenta	Placenta
48	chr6:165722400-165722600	Bivalent Enhancer	Fetal Stomach	stomach
49	chr6:165722400-165722600	Enhancers	Lung	lung
50	chr6:165722400-165722600	Flanking Active TSS	A549	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links